Patents by Inventor Robert John Speirs

Robert John Speirs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
    Publication number: 20120101055
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: November 14, 2011
    Publication date: April 26, 2012
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner
  • METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
    Publication number: 20110005518
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: September 17, 2010
    Publication date: January 13, 2011
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Patent number: 7825095
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: November 2, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner
  • Methods and unit dose formulations for the inhalation administration of tobramycin
    Patent number: 6890907
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: May 10, 2005
    Assignee: Chiron Corporation
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner
  • Methods for the inhalation administration of antibiotics
    Publication number: 20040265241
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 30, 2004
    Applicant: Chiron Corporation
    Inventors: Robert John Speirs, Barbara Ann Shaeffler, Peter Bruce Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Publication number: 20040131555
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: December 22, 2003
    Publication date: July 8, 2004
    Applicant: Chiron Corporation
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Publication number: 20030143162
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: May 17, 2002
    Publication date: July 31, 2003
    Inventors: Robert John Speirs, Barbara Ann Schaeffler, Peter Bruce Challoner